[Parkinson's disease].
Mizuno
Y
Y
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
D015259:Dopamine Agents / Q000627:therapeutic use; D004361:Drug Tolerance; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D011379:Prognosis
D015259:Dopamine Agents; D008996:Monoamine Oxidase Inhibitors; D007980:Levodopa